(Q46709176)

English

Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy

scientific article published on 10 March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18331816

Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18331816

author name string

Ebru Apaydin Dogan

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18331816

Burcu Ekmekci Usta

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18331816

Rengin Bilgen

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18331816

Yesim Senol

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18331816

Berrin Aktekin

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18331816

publication date

10 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18331816

Epilepsy Behavior

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18331816

13

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18331816

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18331816

156-161

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18331816

A new look at the second-generation antiepileptic drugs: a decade of experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Safety and tolerability of oxcarbazepine in elderly patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Clinical pharmacology and pharmacokinetics of oxcarbazepine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Oxcarbazepine: an update of its efficacy in the management of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Multiple treatment comparisons in epilepsy monotherapy trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Efficacy, safety, and tolerability of oxcarbazepine monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Oxcarbazepine reduces seizure frequency in a high proportion of patients with both newly diagnosed and refractory partial seizures in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Outcomes in newly diagnosed localization-related epilepsies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Comparison and predictors of rash associated with 15 antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Rash from antiepileptic drugs: influence by gender, age, and learning disability

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Clinical profile of oxcarbazepine-related angioneurotic edema: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.02.001

7 January 2021

Identifiers

10.1016/J.YEBEH.2008.02.001

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18331816

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18331816

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46709176&oldid=2127683137"